BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 5771189)

  • 21. Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin.
    Cattaneo M; Akkawat B; Kinlough-Rathbone RL; Packham MA; Cimminiello C; Mannucci PM
    Thromb Haemost; 1994 Jan; 71(1):91-4. PubMed ID: 8165651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet heterogeneity. Relationship between buoyant density, size, lipid peroxidation and platelet age.
    Leone G; Agostini A; DeCrescenzo A; Bizzi B
    Scand J Haematol; 1979 Sep; 23(3):204-10. PubMed ID: 504968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UV light-induced changes in washed pig platelets.
    Krajewski T; Wachowicz B; Bończak M; Pietrucha T
    Acta Biochim Pol; 1985; 32(2):155-62. PubMed ID: 4036449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet physiology and abnormalities of platelet function (first of two parts).
    Weiss HJ
    N Engl J Med; 1975 Sep; 293(11):531-41. PubMed ID: 168489
    [No Abstract]   [Full Text] [Related]  

  • 25. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
    Steen VM; Holmsen H; Aarbakke G
    Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of phentolamine, an alpha receptor blocking agent, on epinephrine, ADP and collagen induced factor 4 release and platelet aggregation.
    Kubisz P; Levy-Toledano S; Cronberg S; Pinkhas J; Caen J
    Rev Eur Etud Clin Biol; 1970 Apr; 15(4):429-32. PubMed ID: 4393725
    [No Abstract]   [Full Text] [Related]  

  • 27. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait.
    Okonkwo P; Post R; Sise H
    Thromb Diath Haemorrh; 1970 Jun; 23(3):423-31. PubMed ID: 5432187
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterisation of species differences in the platelet ADP and thrombin response.
    Nylander S; Mattsson C; Lindahl TL
    Thromb Res; 2006; 117(5):543-9. PubMed ID: 15921723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet aggregation and PF3 availability induced by platelet antibodies in thromboasthenia.
    Praga C; Cortellaro M; Pogliani E; Lambertenghi DG
    Acta Univ Carol Med Monogr; 1972; 53():291-6. PubMed ID: 4677605
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of thrombin on the radioactive nucleotides of human washed platelets.
    Ireland DM
    Biochem J; 1967 Nov; 105(2):857-67. PubMed ID: 5584022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Ethylmaleimide induces disaggregation of platelets preaggregated by ADP and thrombin and decreases cytoplasmic calcium level.
    Samal AB; Loiko EN
    Biochemistry (Mosc); 2000 Feb; 65(2):230-6. PubMed ID: 10713553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation.
    Mills DC; Robb IA; Roberts GC
    J Physiol; 1968 Apr; 195(3):715-29. PubMed ID: 5649642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of inhibitors of aggregation on platelet ultrastructure in vitro.
    Mannucci PM; Sirigu F
    Thromb Diath Haemorrh; 1969 Apr; 21(2):354-61. PubMed ID: 5769056
    [No Abstract]   [Full Text] [Related]  

  • 35. Release of adenine nucleotides and platelet factor 4 from platelets of man and four other species.
    Thomas DP; Niewiarowski S; Ream VJ
    J Lab Clin Med; 1970 Apr; 75(4):607-18. PubMed ID: 5444346
    [No Abstract]   [Full Text] [Related]  

  • 36. "New" platelet diseases and their biochemical aspects.
    De Gaetano G
    Acta Vitaminol Enzymol; 1973; 27(5):223-32. PubMed ID: 4596641
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of certain functions of human platelets separated from blood by various means.
    Mason RG; Read MS; Shermer RW
    Am J Pathol; 1974 Aug; 76(2):323-32. PubMed ID: 4276471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
    Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
    Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of drugs on blood platelet characteristics].
    Zbinden G
    Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
    Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
    J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.